Overview

Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
0
Participant gender:
All
Summary
To investigate use of aerosol combined with intravenous antibiotics for the treat of multi-drug resistance gram negative bacterias diagnosed ventilator-associated pneumonia in intensive care unit in a hospital.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shanghai 10th People's Hospital
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Criteria
Inclusion Criteria:

・After 48 hours of mechanical ventilation diagnosed VAP.

Exclusion Criteria:

- Maternal

- who not meet the age limits,

- used amikacin within 15 days,

- allergic to amikacin,

- APACHE II score > 35,

- severe neutropenia unrelated to sepsis or meningitis,

- unable to retain specimens